Hanna P. Stedt
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Disease-phase-specific resource utilization and healthcare costs in metastatic colorectal cancer: a subgroup analysis of the Finnish RAXO study.
Journal: Scandinavian journal of gastroenterology
Published: November 30, 2025
Cost-effectiveness analysis of operative versus non-operative management of colorectal cancer metastases in the Finnish RAXO Study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 08, 2025
Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts.
Journal: International journal of cancer
Published: March 01, 2023
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study).
Journal: Journal of clinical medicine
Published: February 06, 2023
Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
Journal: The British journal of surgery
Published: August 16, 2022
Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.
Journal: British journal of cancer
Published: February 14, 2022
Tomato thymidine kinase-based suicide gene therapy for malignant glioma--an alternative for Herpes Simplex virus-1 thymidine kinase.
Journal: Cancer gene therapy
Published: October 10, 2014
Soluble vascular endothelial growth factor receptor-1 improves therapeutic efficacy of suicide gene therapy in an angiogenesis-independent manner.
Journal: Human gene therapy
Published: July 30, 2014
Last Updated: 09/26/2026